• レポートコード:QYR2104Z2149 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、129ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、内分泌検査のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(タンデム質量分析、イムノアッセイ)、用途別市場規模(病院、商業研究所、外来診療センター、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・内分泌検査の市場動向 ・企業の競争状況、市場シェア ・内分泌検査の種類別市場規模(タンデム質量分析、イムノアッセイ) ・内分泌検査の用途別市場規模(病院、商業研究所、外来診療センター、その他) ・内分泌検査の北米市場規模2016-2027(アメリカ、カナダ) ・内分泌検査のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・内分泌検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・内分泌検査の中南米市場規模2016-2027(メキシコ、ブラジル) ・内分泌検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Abbott Laboratories、AdnaGen、Beckman Coulter/Danaher、Biomedical Diagnostics、BioMerieux、Bio-Rad、Dako、DiaSorin、Eiken、Fujirebio、Instrumentation Laboratory、Kyowa Medex、Matritech、Ortho-Clinical Diagnostics、Roche、Siemens、Sysmex、Thermo Fisher、Tosoh、Wako、Wallac/PE) ・結論 |
The endocrine system is an integrated network that consists of various glands located throughout the body.
Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing.
Market Analysis and Insights: Global Endocrine Testing Market
The global Endocrine Testing market size is projected to reach US$ 11520 million by 2026, from US$ 7384.2 million in 2019, at a CAGR of 6.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endocrine Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endocrine Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endocrine Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endocrine Testing market.
Global Endocrine Testing Scope and Market Size
Endocrine Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endocrine Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tandem Mass Spectrometry
Immunoassay
Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Biomedical Diagnostics
BioMerieux
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tandem Mass Spectrometry
1.2.3 Immunoassay
1.3 Market by Application
1.3.1 Global Endocrine Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Testing Market Perspective (2016-2027)
2.2 Endocrine Testing Growth Trends by Regions
2.2.1 Endocrine Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endocrine Testing Historic Market Share by Regions (2016-2021)
2.2.3 Endocrine Testing Forecasted Market Size by Regions (2022-2027)
2.3 Endocrine Testing Industry Dynamic
2.3.1 Endocrine Testing Market Trends
2.3.2 Endocrine Testing Market Drivers
2.3.3 Endocrine Testing Market Challenges
2.3.4 Endocrine Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Testing Players by Revenue
3.1.1 Global Top Endocrine Testing Players by Revenue (2016-2021)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2016-2021)
3.2 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endocrine Testing Revenue
3.4 Global Endocrine Testing Market Concentration Ratio
3.4.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2020
3.5 Endocrine Testing Key Players Head office and Area Served
3.6 Key Players Endocrine Testing Product Solution and Service
3.7 Date of Enter into Endocrine Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Testing Breakdown Data by Type
4.1 Global Endocrine Testing Historic Market Size by Type (2016-2021)
4.2 Global Endocrine Testing Forecasted Market Size by Type (2022-2027)
5 Endocrine Testing Breakdown Data by Application
5.1 Global Endocrine Testing Historic Market Size by Application (2016-2021)
5.2 Global Endocrine Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Endocrine Testing Market Size (2016-2027)
6.2 North America Endocrine Testing Market Size by Type
6.2.1 North America Endocrine Testing Market Size by Type (2016-2021)
6.2.2 North America Endocrine Testing Market Size by Type (2022-2027)
6.2.3 North America Endocrine Testing Market Size by Type (2016-2027)
6.3 North America Endocrine Testing Market Size by Application
6.3.1 North America Endocrine Testing Market Size by Application (2016-2021)
6.3.2 North America Endocrine Testing Market Size by Application (2022-2027)
6.3.3 North America Endocrine Testing Market Size by Application (2016-2027)
6.4 North America Endocrine Testing Market Size by Country
6.4.1 North America Endocrine Testing Market Size by Country (2016-2021)
6.4.2 North America Endocrine Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Endocrine Testing Market Size (2016-2027)
7.2 Europe Endocrine Testing Market Size by Type
7.2.1 Europe Endocrine Testing Market Size by Type (2016-2021)
7.2.2 Europe Endocrine Testing Market Size by Type (2022-2027)
7.2.3 Europe Endocrine Testing Market Size by Type (2016-2027)
7.3 Europe Endocrine Testing Market Size by Application
7.3.1 Europe Endocrine Testing Market Size by Application (2016-2021)
7.3.2 Europe Endocrine Testing Market Size by Application (2022-2027)
7.3.3 Europe Endocrine Testing Market Size by Application (2016-2027)
7.4 Europe Endocrine Testing Market Size by Country
7.4.1 Europe Endocrine Testing Market Size by Country (2016-2021)
7.4.2 Europe Endocrine Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Testing Market Size (2016-2027)
8.2 Asia-Pacific Endocrine Testing Market Size by Type
8.2.1 Asia-Pacific Endocrine Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endocrine Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endocrine Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Endocrine Testing Market Size by Application
8.3.1 Asia-Pacific Endocrine Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endocrine Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endocrine Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Endocrine Testing Market Size by Region
8.4.1 Asia-Pacific Endocrine Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endocrine Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Endocrine Testing Market Size (2016-2027)
9.2 Latin America Endocrine Testing Market Size by Type
9.2.1 Latin America Endocrine Testing Market Size by Type (2016-2021)
9.2.2 Latin America Endocrine Testing Market Size by Type (2022-2027)
9.2.3 Latin America Endocrine Testing Market Size by Type (2016-2027)
9.3 Latin America Endocrine Testing Market Size by Application
9.3.1 Latin America Endocrine Testing Market Size by Application (2016-2021)
9.3.2 Latin America Endocrine Testing Market Size by Application (2022-2027)
9.3.3 Latin America Endocrine Testing Market Size by Application (2016-2027)
9.4 Latin America Endocrine Testing Market Size by Country
9.4.1 Latin America Endocrine Testing Market Size by Country (2016-2021)
9.4.2 Latin America Endocrine Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Testing Market Size (2016-2027)
10.2 Middle East & Africa Endocrine Testing Market Size by Type
10.2.1 Middle East & Africa Endocrine Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endocrine Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endocrine Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Endocrine Testing Market Size by Application
10.3.1 Middle East & Africa Endocrine Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endocrine Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endocrine Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Endocrine Testing Market Size by Country
10.4.1 Middle East & Africa Endocrine Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endocrine Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrine Testing Introduction
11.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 AdnaGen
11.2.1 AdnaGen Company Details
11.2.2 AdnaGen Business Overview
11.2.3 AdnaGen Endocrine Testing Introduction
11.2.4 AdnaGen Revenue in Endocrine Testing Business (2016-2021)
11.2.5 AdnaGen Recent Development
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Details
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2016-2021)
11.3.5 Beckman Coulter/Danaher Recent Development
11.4 Biomedical Diagnostics
11.4.1 Biomedical Diagnostics Company Details
11.4.2 Biomedical Diagnostics Business Overview
11.4.3 Biomedical Diagnostics Endocrine Testing Introduction
11.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2016-2021)
11.4.5 Biomedical Diagnostics Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Endocrine Testing Introduction
11.5.4 BioMerieux Revenue in Endocrine Testing Business (2016-2021)
11.5.5 BioMerieux Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Details
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Endocrine Testing Introduction
11.6.4 Bio-Rad Revenue in Endocrine Testing Business (2016-2021)
11.6.5 Bio-Rad Recent Development
11.7 Dako
11.7.1 Dako Company Details
11.7.2 Dako Business Overview
11.7.3 Dako Endocrine Testing Introduction
11.7.4 Dako Revenue in Endocrine Testing Business (2016-2021)
11.7.5 Dako Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Details
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Endocrine Testing Introduction
11.8.4 DiaSorin Revenue in Endocrine Testing Business (2016-2021)
11.8.5 DiaSorin Recent Development
11.9 Eiken
11.9.1 Eiken Company Details
11.9.2 Eiken Business Overview
11.9.3 Eiken Endocrine Testing Introduction
11.9.4 Eiken Revenue in Endocrine Testing Business (2016-2021)
11.9.5 Eiken Recent Development
11.10 Fujirebio
11.10.1 Fujirebio Company Details
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Endocrine Testing Introduction
11.10.4 Fujirebio Revenue in Endocrine Testing Business (2016-2021)
11.10.5 Fujirebio Recent Development
11.11 Instrumentation Laboratory
11.11.1 Instrumentation Laboratory Company Details
11.11.2 Instrumentation Laboratory Business Overview
11.11.3 Instrumentation Laboratory Endocrine Testing Introduction
11.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2016-2021)
11.11.5 Instrumentation Laboratory Recent Development
11.12 Kyowa Medex
11.12.1 Kyowa Medex Company Details
11.12.2 Kyowa Medex Business Overview
11.12.3 Kyowa Medex Endocrine Testing Introduction
11.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2016-2021)
11.12.5 Kyowa Medex Recent Development
11.13 Matritech
11.13.1 Matritech Company Details
11.13.2 Matritech Business Overview
11.13.3 Matritech Endocrine Testing Introduction
11.13.4 Matritech Revenue in Endocrine Testing Business (2016-2021)
11.13.5 Matritech Recent Development
11.14 Ortho-Clinical Diagnostics
11.14.1 Ortho-Clinical Diagnostics Company Details
11.14.2 Ortho-Clinical Diagnostics Business Overview
11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
11.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2016-2021)
11.14.5 Ortho-Clinical Diagnostics Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Endocrine Testing Introduction
11.15.4 Roche Revenue in Endocrine Testing Business (2016-2021)
11.15.5 Roche Recent Development
11.16 Siemens
11.16.1 Siemens Company Details
11.16.2 Siemens Business Overview
11.16.3 Siemens Endocrine Testing Introduction
11.16.4 Siemens Revenue in Endocrine Testing Business (2016-2021)
11.16.5 Siemens Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Details
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Endocrine Testing Introduction
11.17.4 Sysmex Revenue in Endocrine Testing Business (2016-2021)
11.17.5 Sysmex Recent Development
11.18 Thermo Fisher
11.18.1 Thermo Fisher Company Details
11.18.2 Thermo Fisher Business Overview
11.18.3 Thermo Fisher Endocrine Testing Introduction
11.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2016-2021)
11.18.5 Thermo Fisher Recent Development
11.18 Tosoh
.1 Tosoh Company Details
.2 Tosoh Business Overview
.3 Tosoh Endocrine Testing Introduction
.4 Tosoh Revenue in Endocrine Testing Business (2016-2021)
.5 Tosoh Recent Development
11.20 Wako
11.20.1 Wako Company Details
11.20.2 Wako Business Overview
11.20.3 Wako Endocrine Testing Introduction
11.20.4 Wako Revenue in Endocrine Testing Business (2016-2021)
11.20.5 Wako Recent Development
11.21 Wallac/PE
11.21.1 Wallac/PE Company Details
11.21.2 Wallac/PE Business Overview
11.21.3 Wallac/PE Endocrine Testing Introduction
11.21.4 Wallac/PE Revenue in Endocrine Testing Business (2016-2021)
11.21.5 Wallac/PE Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Endocrine Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tandem Mass Spectrometry
Table 3. Key Players of Immunoassay
Table 4. Global Endocrine Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Endocrine Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Endocrine Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Endocrine Testing Market Share by Regions (2016-2021)
Table 8. Global Endocrine Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Endocrine Testing Market Share by Regions (2022-2027)
Table 10. Endocrine Testing Market Trends
Table 11. Endocrine Testing Market Drivers
Table 12. Endocrine Testing Market Challenges
Table 13. Endocrine Testing Market Restraints
Table 14. Global Endocrine Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Endocrine Testing Market Share by Players (2016-2021)
Table 16. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Testing as of 2020)
Table 17. Ranking of Global Top Endocrine Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Endocrine Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Endocrine Testing Product Solution and Service
Table 21. Date of Enter into Endocrine Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Endocrine Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Endocrine Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Endocrine Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Endocrine Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Endocrine Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Endocrine Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Endocrine Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Endocrine Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Endocrine Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Endocrine Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Endocrine Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Endocrine Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Endocrine Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Endocrine Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Endocrine Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Endocrine Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Endocrine Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Endocrine Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Endocrine Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Endocrine Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Endocrine Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endocrine Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endocrine Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endocrine Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Endocrine Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Endocrine Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Endocrine Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Endocrine Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Endocrine Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Endocrine Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Endocrine Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Endocrine Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Endocrine Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endocrine Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endocrine Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endocrine Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Endocrine Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Endocrine Testing Product
Table 64. Abbott Laboratories Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. AdnaGen Company Details
Table 67. AdnaGen Business Overview
Table 68. AdnaGen Endocrine Testing Product
Table 69. AdnaGen Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 70. AdnaGen Recent Development
Table 71. Beckman Coulter/Danaher Company Details
Table 72. Beckman Coulter/Danaher Business Overview
Table 73. Beckman Coulter/Danaher Endocrine Testing Product
Table 74. Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 75. Beckman Coulter/Danaher Recent Development
Table 76. Biomedical Diagnostics Company Details
Table 77. Biomedical Diagnostics Business Overview
Table 78. Biomedical Diagnostics Endocrine Testing Product
Table 79. Biomedical Diagnostics Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 80. Biomedical Diagnostics Recent Development
Table 81. BioMerieux Company Details
Table 82. BioMerieux Business Overview
Table 83. BioMerieux Endocrine Testing Product
Table 84. BioMerieux Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 85. BioMerieux Recent Development
Table 86. Bio-Rad Company Details
Table 87. Bio-Rad Business Overview
Table 88. Bio-Rad Endocrine Testing Product
Table 89. Bio-Rad Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 90. Bio-Rad Recent Development
Table 91. Dako Company Details
Table 92. Dako Business Overview
Table 93. Dako Endocrine Testing Product
Table 94. Dako Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 95. Dako Recent Development
Table 96. DiaSorin Company Details
Table 97. DiaSorin Business Overview
Table 98. DiaSorin Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 99. DiaSorin Recent Development
Table 100. Eiken Company Details
Table 101. Eiken Business Overview
Table 102. Eiken Endocrine Testing Product
Table 103. Eiken Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 104. Eiken Recent Development
Table 105. Fujirebio Company Details
Table 106. Fujirebio Business Overview
Table 107. Fujirebio Endocrine Testing Product
Table 108. Fujirebio Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 109. Fujirebio Recent Development
Table 110. Instrumentation Laboratory Company Details
Table 111. Instrumentation Laboratory Business Overview
Table 112. Instrumentation Laboratory Endocrine Testing Product
Table 113. Instrumentation Laboratory Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 114. Instrumentation Laboratory Recent Development
Table 115. Kyowa Medex Company Details
Table 116. Kyowa Medex Business Overview
Table 117. Kyowa Medex Endocrine Testing Product
Table 118. Kyowa Medex Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 119. Kyowa Medex Recent Development
Table 120. Matritech Company Details
Table 121. Matritech Business Overview
Table 122. Matritech Endocrine Testing Product
Table 123. Matritech Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 124. Matritech Recent Development
Table 125. Ortho-Clinical Diagnostics Company Details
Table 126. Ortho-Clinical Diagnostics Business Overview
Table 127. Ortho-Clinical Diagnostics Endocrine Testing Product
Table 128. Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 129. Ortho-Clinical Diagnostics Recent Development
Table 130. Roche Company Details
Table 131. Roche Business Overview
Table 132. Roche Endocrine Testing Product
Table 133. Roche Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 134. Roche Recent Development
Table 135. Siemens Company Details
Table 136. Siemens Business Overview
Table 137. Siemens Endocrine Testing Product
Table 138. Siemens Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 139. Siemens Recent Development
Table 140. Sysmex Company Details
Table 141. Sysmex Business Overview
Table 142. Sysmex Endocrine Testing Product
Table 143. Sysmex Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 144. Sysmex Recent Development
Table 145. Thermo Fisher Company Details
Table 146. Thermo Fisher Business Overview
Table 147. Thermo Fisher Endocrine Testing Product
Table 148. Thermo Fisher Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 149. Thermo Fisher Recent Development
Table 150. Tosoh Company Details
Table 151. Tosoh Business Overview
Table 152. Tosoh Endocrine Testing Product
Table 153. Tosoh Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 154. Tosoh Recent Development
Table 155. Wako Company Details
Table 156. Wako Business Overview
Table 157. Wako Endocrine Testing Product
Table 158. Wako Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 159. Wako Recent Development
Table 160. Wallac/PE Company Details
Table 161. Wallac/PE Business Overview
Table 162. Wallac/PE Endocrine Testing Product
Table 163. Wallac/PE Revenue in Endocrine Testing Business (2016-2021) & (US$ Million)
Table 164. Wallac/PE Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Testing Market Share by Type: 2020 VS 2027
Figure 2. Tandem Mass Spectrometry Features
Figure 3. Immunoassay Features
Figure 4. Global Endocrine Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Commercial Laboratories Case Studies
Figure 7. Ambulatory Care Centres Case Studies
Figure 8. Other Setting Case Studies
Figure 9. Endocrine Testing Report Years Considered
Figure 10. Global Endocrine Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Endocrine Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Endocrine Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Endocrine Testing Market Share by Regions (2022-2027)
Figure 14. Global Endocrine Testing Market Share by Players in 2020
Figure 15. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Endocrine Testing Revenue in 2020
Figure 17. Global Endocrine Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Endocrine Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Endocrine Testing Market Share by Type (2016-2027)
Figure 21. North America Endocrine Testing Market Share by Application (2016-2027)
Figure 22. North America Endocrine Testing Market Share by Country (2016-2027)
Figure 23. United States Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endocrine Testing Market Share by Type (2016-2027)
Figure 27. Europe Endocrine Testing Market Share by Application (2016-2027)
Figure 28. Europe Endocrine Testing Market Share by Country (2016-2027)
Figure 29. Germany Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endocrine Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Endocrine Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Endocrine Testing Market Share by Region (2016-2027)
Figure 39. China Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endocrine Testing Market Share by Type (2016-2027)
Figure 47. Latin America Endocrine Testing Market Share by Application (2016-2027)
Figure 48. Latin America Endocrine Testing Market Share by Country (2016-2027)
Figure 49. Mexico Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endocrine Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Endocrine Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Endocrine Testing Market Share by Country (2016-2027)
Figure 55. Turkey Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Endocrine Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Laboratories Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 59. AdnaGen Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 60. Beckman Coulter/Danaher Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 61. Biomedical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 62. BioMerieux Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 63. Bio-Rad Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 64. Dako Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 65. DiaSorin Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 66. Eiken Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 67. Fujirebio Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 68. Instrumentation Laboratory Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 69. Kyowa Medex Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 70. Matritech Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 71. Ortho-Clinical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 72. Roche Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 73. Siemens Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 74. Sysmex Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 75. Thermo Fisher Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 76. Tosoh Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 77. Wako Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 78. Wallac/PE Revenue Growth Rate in Endocrine Testing Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed